Patient P-01779

Synthetic patientNBL-101 · Day 116 · 45–54 · M · baseline S15Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Improving

GI state

Deteriorating

Inflammatory state

Deteriorating

Nutritional resilience

Declining

Discontinuation risk

35%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S15

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

GI instability+19
Inflammatory activity+9
Nutritional resilience-7
Toxicity-6
Treatment adherence+2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

19.4/100

worsening · +2.6 vs previous 14 d

Toxicity

Blood

11.2/100

worsening · +10.4 vs previous 14 d

Sleep quality

Wearable

74.8/100

stable · -0.3 vs previous 14 d

Energy level

Daily log

7.2/10

stable · -0.2 vs previous 14 d

Stress level

Daily log

2.9/10

worsening · +0.2 vs previous 14 d

Steps

Wearable

5,715

worsening · -418 vs previous 14 d

Adherence

Companion

92 %

stable · +1.3 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 90 from the failing basin, 6 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

Nothing clearly counter-productive in the record.

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Spicy / capsaicin
+1.7no signal · 33%
Insoluble fibre
+1.1no signal · 15%
Simple carbohydrates
+0.5no signal · 15%
Alcohol
+0.5no signal · 15%
Histamine load
-0.4no signal · 15%
Dietary fat load
+0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

CYP2D6 Rapid metabolizer
Expected exposure

Microbiome

Shannon diversity 3.3 · butyrate capacity 73/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 59 ms
Sleep: 7.8 h
Steps: 6,504
Resting HR: 56 bpm

Daily log: GI score 19, nutritional resilience 66, adherence 92.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01766	43%	S05	AD-05	no change	90
P-01804	27%	S19	AD-05	improved	61
P-01541	25%	S09	AD-05	no change	43
P-01329	45%	S08	BR-03	improved	79
P-01677	42%	S05	BR-03	no change	86
P-01495	40%	S07	BR-03	improved	85
P-01689	25%	S13	BR-03	no change	50
P-01654	42%	S08	CR-01	improved	85
P-01430	25%	S05	CR-01	improved	54
P-01479	40%	S15	DT-01	improved	84
P-01855	36%	S04	DT-01	improved	73
P-01724	31%	S10	DT-01	improved	63